3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
13
Stomach Neoplasms
2
Colonic Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Colorectal Cancer Metastatic
1
Advanced Malignancies
1
Interventions
Oxaliplatin
14
Leucovorin
12
Fluorouracil
12
Cetuximab
10
Bevacizumab
9
pembrolizumab
7
Specimen Handling
7
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Irinotecan
5
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
Capecitabine
4
fludarabine
3
cemiplimab
3
Laparoscopy
3
Folfox protocol
3
Early Intervention, Educational
3
Cyclophosphamide
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
pertuzumab
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
HMPL-013
×
90 days
×
Clear all
NCT07510932
2026-04-06
FIRST-K
Korea University Anam Hospital
Phase 2
Not yet recruiting
88 enrolled
NCT07011576
2026-03-18
FRUITFUL
SCRI Development Innovations, LLC
Phase 2
Recruiting
60 enrolled